An additional cause of prescribing error I would like to add another category of error to the helpful description given by Slight and colleagues. 1 A patient of mine was approached to take part in a trial of medication: the REVEAL study (http://www.ctsu.ox.ac.uk/~reveal/). This seeks to test a new drug, anacetrapib, in the context of lipid lowering. The paperwork was scanned into our EMIS Web system and I reviewed the letter. The EMIS prescribing module allows 'red' drugs to be included in the prescribing record so that possible interactions with proposed new medication is highlighted.
Unfortunately anacetrapib is not included in the drop down menu and so I contacted the study organisers. There is no requirement for medication being tested in a clinical trial to be available in GP systems for addition to the prescription screen. I can foresee circumstances when interacting medication could be added un-knowingly by myself or colleagues. This gap in the system needs to be addressed and I have contacted the National Research Ethics Service for guidance. 
non-directed altruistic kidney donation
Neuberger and Keogh's editorial on organ donation makes a very brief reference to altruistic kidney donation. 1 When a mechanism to support the process was established in 2006 it was anticipated that there would perhaps be 10 or so such operations per year. This was the case initially but word has got around, principally as a result of media stories, and numbers have increased with 76 altruistic donations in 2012/2013. 2 We do not know the size of the pool of people willing to donate in this way but surveys in several countries including the UK have shown that a substantial proportion are willing to consider giving a kidney to a stranger. 3 In the UK there is a clear and well-planned assessment pathway in place in transplant units. Publicity has increased awareness which has led to more volunteers. NHS staff involved in transplantation have become increasingly confident that altruistic donors are generally ordinary, healthy people with no excess of psychological morbidity. They come from diverse backgrounds and include a number of doctors and nurses.
GPs may be approached by individuals interested in the possibility of donating. They don't need to know the intricacies of the cross-matching process but they can assure them that the risks associated with nephrectomy, although not trivial, are still small with a mortality of less than 1 in 3000 and there is evidence that donors have a higher than average life expectancy. 4 There are numerous resources on the web including a charity called Give csA pass rates
We all know the figures published by the RCGP showing differences in male versus female, white versus BME, and UK graduates versus IMGs. However, I have suspected for years that the male/female difference is due to the male inability (relatively speaking), to process several possible outcomes, as opposed to jumping to the most likely and then re-evaluating, is at the centre of this issue. The possible solution to this is teaching exam technique. I have always been puzzled by the IMG issue, as apparently has everyone else, with suggestions of bias and worse being made; similar differences also occur at AKT.
I suggest a seemingly ludicrous idea, that the difference occurs because of the fact that the data are published.
Malcolm Gladwell's book Blink includes the already accepted idea of 'priming'. In brief, the fact that IMG candidates are told (repeatedly and unavoidably) that they have much less chance of success primes them to fail
As an example, the standardised test for US College entrance was given to two groups of applicants. Pre-test priming by including their race on a pre-test questionnaire reduced the scores of, in this case, the African-American candidates by up to 50%. Asked afterwards none of them agreed that the pre-test questionnaire had ANY effect.
The postcode lottery of GP training: Time Out of Programme
I was encouraged to read the article by Franey et al 1 about the undoubted value of an international Time Out of Programme Experience (OOPE), particularly in a low or middle income country. In the Severn School of Primary Care (Severn Postgraduate Medical Education) we have been promoting this activity for 5 years, inspired by the Crisp report. 2 The many gains 3 that accrue have informed our selection criteria: how will the OOPE benefit the candidate's career progression, general practice in the NHS, and the health of the country of the placement, and why does the OOPE need to be taken at this particular time?
To date we have had overseas OOPE doctors (OOPEs) in Uganda, Malawi, Madagascar, KwaZulu-Natal, Solomon Islands, Zambia, Northern India, Costa Rica, Nicaragua, and the Cook Islands. Short descriptions of their inspirational experiences are available on our website: http://www.primarycare. severndeanery.nhs.uk/training/trainees/ out-of-programme-experience-andopportunities-oope/our-recent-oopetrainees-and-what-they-got-up-to/ We finance placements for our intending OOPEs on a local 3-day course in overseas medicine, which is aimed at doctors and nurses preparing to work in low resource countries. We provide a series of in-house meetings where returning OOPEs share their experiences and potential OOPEs have an opportunity to discuss preparatory arrangements. We emphasise and try to ensure that all our OOPEs have clinical
